{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:07:25Z","timestamp":1790233645239,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejradiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ejrad.2026.113137","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T06:00:25Z","timestamp":1785996025000},"page":"113137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Baseline dual-energy CT iodine uptake predicts systemic but not lesion-level progression in immunotherapy-treated metastatic melanoma"],"prefix":"10.1016","volume":"204","author":[{"given":"Vincent","family":"Bleymehl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seval","family":"Akbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan Constantin","family":"Schepers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz","family":"Schroth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul V.","family":"Op gen Oorth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Winneknecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devayani","family":"Machiraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julius C.","family":"Holzschuh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin S.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica C.","family":"Hassel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz-Peter","family":"Schlemmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas T.","family":"Rotkopf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejrad.2026.113137_b0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa2407417","article-title":"Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma","volume":"392","author":"Wolchok","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejrad.2026.113137_b0010","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1080\/14737140.2023.2278509","article-title":"Immune checkpoint inhibitors in advanced cutaneous melanoma: a systematic review and meta-analysis of efficacy and review of characteristics","volume":"23","author":"Mahdiabadi","year":"2023","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.ejrad.2026.113137_b0015","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1056\/NEJMoa1910836","article-title":"Five-year survival with combined nivolumab and ipilimumab in advanced melanoma","volume":"381","author":"Larkin","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejrad.2026.113137_b0020","first-page":"744","article-title":"Resistance mechanisms in melanoma to immuneoncologic therapy with checkpoint inhibitors","volume":"2","author":"Fenton","year":"2019","journal-title":"Cancer Drug Resist."},{"key":"10.1016\/j.ejrad.2026.113137_b0025","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1245\/s10434-020-08657-6","article-title":"Mixed response to immunotherapy in patients with metastatic melanoma","volume":"27","author":"Rauwerdink","year":"2020","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ejrad.2026.113137_b0030","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1187840","article-title":"Nivolumab plus ipilimumab in metastatic melanoma: a critical appraisal focused on specific subpopulations","volume":"13","author":"V\u00e1zquez-Montero","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejrad.2026.113137_b0035","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.3390\/diagnostics13193065","article-title":"Artificial intelligence and radiomics: clinical applications for patients with advanced melanoma treated with immunotherapy","volume":"13","author":"McGale","year":"2023","journal-title":"Diagnostics"},{"key":"10.1016\/j.ejrad.2026.113137_b0040","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003261","article-title":"A machine learning model trained on dual-energy CT radiomics significantly improves immunotherapy response prediction for patients with stage IV melanoma","volume":"9","author":"Brendlin","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ejrad.2026.113137_b0045","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1158\/1078-0432.CCR-20-0020","article-title":"Radiomics, tumor volume, and blood biomarkers for early prediction of pseudoprogression in patients with metastatic melanoma treated with immune checkpoint inhibition","volume":"26","author":"Basler","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejrad.2026.113137_b0050","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejca.2022.07.034","article-title":"Imaging to predict checkpoint inhibitor outcomes in cancer","volume":"175","author":"Ter Maat","year":"2022","journal-title":"A systematic review, Eur J Cancer"},{"key":"10.1016\/j.ejrad.2026.113137_b0055","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.1118\/1.4922654","article-title":"Performance of today\u2019s dual energy CT and future multi energy CT in virtual non-contrast imaging and in iodine quantification: a simulation study","volume":"42","author":"Faby","year":"2015","journal-title":"Med. Phys."},{"key":"10.1016\/j.ejrad.2026.113137_b0060","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2214\/AJR.21.26636","article-title":"Dual-energy CT vital iodine tumor burden for response assessment in patients with metastatic GIST undergoing TKI therapy: Comparison with standard CT and FDG PET\/CT criteria","volume":"218","author":"Meyer","year":"2022","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.ejrad.2026.113137_b0065","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s40644-023-00547-w","article-title":"Early evaluation of liver metastasis using spectral CT to predict outcome in patients with colorectal cancer treated with FOLFOXIRI and bevacizumab","volume":"23","author":"Li","year":"2023","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.ejrad.2026.113137_b0070","first-page":"417","article-title":"Liver metastasis and treatment outcome with Anti-PD-1 monoclonal antibody in patients with melanoma and NSCLC, cancer","volume":"5","author":"Tumeh","year":"2017","journal-title":"Immunol. Res."},{"key":"10.1016\/j.ejrad.2026.113137_b0075","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1007\/s00330-025-11351-4","article-title":"Dual-energy CT iodine concentration as a biomarker for immunotherapy treatment response in metastatic melanoma and renal cell carcinoma patients","volume":"35","author":"Wiley","year":"2025","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ejrad.2026.113137_b0080","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejrad.2017.02.024","article-title":"Improved detection of melanoma metastases by iodine maps from dual energy CT","volume":"90","author":"Uhrig","year":"2017","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.ejrad.2026.113137_b0085","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.1007\/s00330-018-5424-0","article-title":"D\u2019Anastasi, Towards volumetric thresholds in RECIST 1.1: Therapeutic response assessment in hepatic metastases","volume":"28","author":"Winter","year":"2018","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ejrad.2026.113137_b0090","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1007\/s00330-020-07330-6","article-title":"Preoperative normalized iodine concentration derived from spectral CT is correlated with early recurrence of hepatocellular carcinoma after curative resection","volume":"31","author":"Luo","year":"2021","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ejrad.2026.113137_b0095","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s10434-999-0070-z","article-title":"Angiogenesis correlates with metastasis in melanoma","volume":"6","author":"Neitzel","year":"1999","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ejrad.2026.113137_b0100","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrclinonc.2018.29","article-title":"Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges","volume":"15","author":"Fukumura","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ejrad.2026.113137_b0105","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004884","article-title":"Unveiling the tumor immune microenvironment of organ-specific melanoma metastatic sites","volume":"10","author":"Conway","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ejrad.2026.113137_b0110","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3322\/caac.21409","volume":"67","author":"Gershenwald","year":"2017","journal-title":"Cancer J. Clin."},{"key":"10.1016\/j.ejrad.2026.113137_b0115","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3109\/0284186X.2015.1043026","article-title":"Prognostic role of lactate dehydrogenase in solid tumors: a systematic review and meta-analysis of 76 studies","volume":"54","author":"Petrelli","year":"2015","journal-title":"Acta Oncol."},{"key":"10.1016\/j.ejrad.2026.113137_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101072","article-title":"The prognostic value of circulating tumor DNA in patients with melanoma: a systematic review and meta-analysis","volume":"14","author":"Feng","year":"2021","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.ejrad.2026.113137_b0125","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1148\/radiol.2017170896","article-title":"Intermanufacturer comparison of dual-energy CT iodine quantification and monochromatic attenuation: a phantom study","volume":"287","author":"Jacobsen","year":"2018","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2026.113137_b0130","doi-asserted-by":"crossref","first-page":"4438","DOI":"10.1007\/s00330-020-07611-0","article-title":"Inter-scan and inter-scanner variation of quantitative dual-energy CT: evaluation with three different scanner types","volume":"31","author":"Lennartz","year":"2021","journal-title":"Eur. Radiol."}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X26004857?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X26004857?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:48:18Z","timestamp":1790232498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X26004857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":26,"alternative-id":["S0720048X26004857"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2026.113137","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Baseline dual-energy CT iodine uptake predicts systemic but not lesion-level progression in immunotherapy-treated metastatic melanoma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2026.113137","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113137"}}